UW recruiting patients for antibody trial
Friday, October 9, 2020
Researchers at UW Medicine and the Fred Hutchinson Cancer Research Center say they're collaborating to test monoclonal antibodies created by Regeneron Pharmaceuticals to prevent COVID-19. Those researchers are early in the process of recruiting patients to determine the treatment's efficacy. To qualify for the study, participants must have a confirmed household member test positive for SARS-CoV-2, the virus that causes COVID-19.
Learn more
